Lybradyn

Lybradyn is a biotechnology company based in San Diego, California, that specializes in synthetic biology and metabolic engineering for the production of high-value natural products. Founded by Dr. Mark Burk, a pioneer in the field of bio-based chemicals, the company developed a proprietary yeast-based fermentation platform specifically optimized for the manufacturing of cannabinoids and their derivatives. Lybradyn's technology aims to provide a sustainable, high-purity, and cost-effective alternative to traditional plant-based extraction for the pharmaceutical and nutraceutical industries. In December 2021, the company's technology assets and intellectual property were acquired by Geno (formerly Genomatica) to enhance its functional ingredients portfolio. The integration of Lybradyn's platform allows for the scalable production of rare and minor cannabinoids through microbial fermentation.